Volume 18, Number 1—January 2012
Intestinal Toxemia Botulism in 3 Adults, Ontario, Canada, 2006–2008
|Case-patient no.||Age, y/sex||Dates admitted to hospital and discharged||Clinical findings||Gastrointestinal history||Clostridium botulinum serotype||No. days stool sample positive for C. botulinum*||Supportive care; antitoxin; administration date|
|1||63/F||2006 Nov 22||Abdominal pain, diarrhea, dysphagia, diplopia, weakness||Crohn disease, short bowel syndrome, remote bowel surgery||A||61||Intubation and ventilation; bivalent type A and B, monovalent type E; 2006 Nov 23|
|2||50/F||2007 Feb 8; 2007 Sep||Dysphagia, double vision, weakness, difficulty breathing||Crohn disease, bowel resections||A and B||56||Intubation and ventilation; bivalent type A and B, monovalent type E; 2007 Feb 23|
|3||45/M||2008 Jan 8; 2008 Feb 27||Abdominal distension and obstruction, aphonia, diplopia, dry mouth, dysphagia, dysphonia, ptosis||Unremarkable||B||41||Bivalent type A and B, monovalent type E; 2008 Jan 14|
*Total number of days that C. botulinum spores or neurotoxins were detected in clinical samples.